Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Aug;14(8):564-74.
doi: 10.1007/s12094-012-0842-y. Epub 2012 Jul 18.

Novel antiangiogenic therapies against advanced hepatocellular carcinoma (HCC)

R A Pazo-Cid  1 , M Lanzuela, G Esquerdo, J L Pérez-Gracia, A Antón, G Amigo, J Martínez Trufero, A L García-Otín, P Martín-Duque
Affiliations

Novel antiangiogenic therapies against advanced hepatocellular carcinoma (HCC)

R A Pazo-Cid et al. Clin Transl Oncol. 2012 Aug.

Abstract

Angiogenesis is a cornerstone in the process of hepatocarcinogenesis. In the sorafenib era, other antiangiogenic targeted drugs, such as monoclonal antibodies and a new generation of tyrosine kinase inhibitors, have been shown in phase II trials to be safe and effective in the treatment of advanced hepatocellular carcinoma. Several currently active phase III trials are testing these drugs, both in first- and second-line settings. Strategies to overcome primary and acquired resistance to antiangiogenic therapy are urgently needed. Novel biomarkers may help in improving the efficacy of drugs targeting angiogenesis.

PubMed Disclaimer

References

    1. Hepatology. 2008 Oct;48(4):1312-27 - PubMed
    1. Nat Rev Clin Oncol. 2011 May 31;8(7):393-404 - PubMed
    1. Cancer Cell. 2005 Oct;8(4):299-309 - PubMed
    1. J Clin Oncol. 2010 Feb 20;28(6):949-54 - PubMed
    1. Ann Surg Oncol. 2011 Feb;18(2):589-96 - PubMed

MeSH terms

LinkOut - more resources